Sai Parenteral's
add_icon

Sai Parenteral's

523.35
+0.80
(0.15%)
Market Cap
2,312.12 Cr
PE Ratio
111.01
Volume
39,054.00
Day High - Low
527.90 - 515.55
52W High-Low
706.00 - 400.00
ann
There are 2 new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,312.12 Cr
EPS
4.36
PE Ratio
111.01
PB Ratio
4.70
Book Value
111.09
EBITDA
47.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
2.88
Debt to Equity
0.96
Forecast For
Actual

Company News

View All News
Caret
neutral
Sai Parenterals Limited approved all 12 resolutions at its AGM on September 10, 2026, including director reappointments, ESOP ratification, and related-party transactions. Promoter voting participation was 100%.
positive
Sai Parenteral secures Rs 204 crore OTC supply deal with Australian pharmacy chain. The 3-year contract covers manufacturing and distribution. Total order book now stands at Rs 5613 crore.
positive
Confirmed Rs 204 crore renewal for OTC supply. Total backlog stands at Rs 5613 crore, representing 41.8 quarters of revenue. Q2FY27 inflow was Rs 2804 crore.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,840.00
#1 4,41,477.63
36.91
#1 61,673.90
12.69
#1 11,565
26.53
34.00
9,322.00
2,47,469.81
85.36
11,067.00
13.95
2,568
65.50
63.65
4,965.50
1,88,871.66
86.95
13,886.20
20.34
2,138
3.28
52.16
1,119.10
1,12,607.65
24.28
27,657.90
17.64
5,026
-34.90
45.64
1,366.00
1,10,351.67
33.22
29,044.60
2.24
3,870
-39.18
35.27
1,969.00
1,06,297.76
95.94
6,867.80
22.01
890
#1 123.93
68.28
1,165.50
97,280.68
29.91
35,058.60
3.90
4,158
-69.10
47.72
1,679.80
96,651.98
25.88
34,145.20
5.56
3,503
25.21
57.04
2,095.00
95,790.22
#1 17.09
29,038.90
#1 26.75
5,356
16.00
28.17
2,280.00
94,163.08
44.87
14,636.40
14.85
1,938
29.13
37.57

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
137.94 %
Net Income Growth
-0.69 %
Cash Flow Change
180.69 %
ROE
-80.88 %
ROCE
-87.66 %
EBITDA Margin (Avg.)
-50.41 %

Quarterly Financial Results

Quarterly Financials
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
35
55
99
201
182
Expenses
29
42
100
172
155
EBITDA
6
13
-0
29
27
Operating Profit %
14 %
21 %
-4 %
13 %
13 %
Depreciation
2
1
6
8
8
Interest
3
2
5
8
9
Profit Before Tax
2
9
-12
12
10
Tax
1
3
-5
-1
2
Net Profit
1
6
-7
13
8
EPS in ₹
0.11
34.41
-2.22
4.02
1.79

Order Value Trend

FY 2026-27 order value₹5,817.00 Cr
FY 2026-278 Orders
Australia's leading pharmacy n...
44.70%
Australia's Leading Pharmacy N...
44.70%
PILL CORP, Bulacan, Philippine...
3.59%
One of Australia's leading pha...
3.51%
Australia's Leading Pharmacy N...
3.51%

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
134
268
272
1,424
Fixed Assets
45
70
53
364
Current Assets
82
187
200
822
Capital Work in Progress
2
0
1
212
Investments
0
0
0
0
Other Assets
88
198
219
848
Total Equity & Liabilities
134
268
272
1,424
Current Liabilities
77
153
162
573
Non Current Liabilities
26
39
14
357
Total Equity
32
76
96
495
Reserve & Surplus
24
61
80
469
Share Capital
7
13
13
22

Cash Flow

Cash Flow
2023
2024
2025
2026
Net Cash Flow
-8
3
-2
415
Investing Activities
-19
-46
0
-274
Operating Activities
-13
-30
33
93
Financing Activities
24
79
-36
596

Share Holding

% Holding
Sept 2025
Mar 2026
Apr 2026
Jun 2026
Promoter
61.23 %
51.16 %
51.16 %
51.16 %
FIIs
0.00 %
5.73 %
5.73 %
4.03 %
DIIs
0.00 %
12.86 %
12.86 %
8.53 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
22.67 %
22.67 %
25.33 %
Others
38.77 %
7.59 %
7.59 %
10.95 %
No of Share Holders
119
143
7,687
9,312

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2026 478.60 486.70
11 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Aug 2026 554.90 587.50
10 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
10 Sept 2026 587.50 526.15

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizers Report1 day ago
Shareholder Meeting / Postal Ballot-Outcome of AGM1 day ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 25, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2026
Book Closure Intimation For 25Th Annual General MeetingAug 19, 2026
Reg. 34 (1) Annual Report.Aug 19, 2026
Notice Of 25Th Annual General MeetingAug 19, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2026
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 11, 2026
Financial Results For The Quarter Ended 30.06.2026.Aug 11, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August 2026.Aug 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2026
Board Meeting Intimation for Meeting Proposed To Be Held On 11Th August 2026.Aug 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 06, 2026
Board Meeting Outcome for Outcome Of The Board MeetingJul 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Closure of Trading WindowJun 29, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 29, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2026
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 23, 2026
Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31.03.2026May 23, 2026
Un Audited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025May 23, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 23.05.2026May 23, 2026
Board Meeting Intimation for The Notice Of Board MeetingMay 19, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
Results-Delay in Financial ResultsApr 22, 2026
Board Meeting Outcome for Outcome Of Board MeetingApr 20, 2026
Board Meeting Intimation for INTIMATION OF BOARD MEETING WHICH IS PROPOSED TO BE HELD ON 20TH OF APRIL 2026Apr 14, 2026
Closure of Trading WindowApr 06, 2026
Intimation Under Regulation 30(5) Of SEBIApr 06, 2026
Listing of Equity Shares of Sai Parenterals LtdApr 02, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
0.00%
-56650
-0.97%
0.00%
Bandhan Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Mid Cap Fund Direct-Growth
0.00%
0
0.00%
-0.05%
Quant Momentum Fund Direct-Growth
0.00%
0
0.00%
0.00%
Quant Small Cap Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
43.63
ATR(14)
Less Volatile
18.69
STOCH(9,6)
Neutral
54.00
STOCH RSI(14)
Overbought
81.06
MACD(12,26)
Bullish
0.86
ADX(14)
Weak Trend
23.34
UO(9)
Bearish
47.48
ROC(12)
Downtrend And Accelerating
-1.01
WillR(14)
Neutral
-52.37